Aible named Mount Sinai as a joint customer in its March 2026 announcement describing planned Nebius AI Cloud demonstrations at NVIDIA GTC. The announcement highlighted agent portability from local devices to Nebius.
Muhammad Parvaz, an associate professor at the Icahn School of Medicine at Mount Sinai, described exploratory analyses of locally stored health-related data using Aible and an NVIDIA DGX Spark / Dell Pro Max GB10 system. All model components ran on the standalone device, keeping data under institutional control. NVIDIA NeMo Guardrails identified potentially sensitive information during processing. After internal validation, the analytical agent was automatically transferred to Nebius cloud without transferring the underlying research data.
Aible announces SafeClaw and Mount Sinai's Nebius research-agent deployment
15 Oct 2026 · ACCESS Newswire · Web page
Aible names Mount Sinai as a joint customer for its Nebius AI Cloud demonstration. Muhammad Parvaz of the Icahn School of Medicine at Mount Sinai describes local exploratory health-data analyses followed by transfer of the validated analytical agent to Nebius without the underlying research data.
Aible announces SafeClaw and Mount Sinai's Nebius research-agent deployment15 Oct 2026 · ACCESS Newswire · Web pageAible names Mount Sinai as a joint customer for its Nebius AI Cloud demonstration. Muhammad Parvaz of the Icahn School of Medicine at Mount Sinai describes local exploratory health-data analyses followed by transfer of the validated analytical agent to Nebius without the underlying research data.
Aible Launches SafeClaw Long-Running Agents and Presents at Eight Partner Booths and Sessions at NVIDIA GTC 2026
16 Mar 2026 · Newswire · Web page
Aible names Mount Sinai as a joint customer for Nebius AI Cloud. Muhammad Parvaz describes moving a locally validated analytical agent to Nebius cloud without moving research data.
Aible Launches SafeClaw Long-Running Agents and Presents at Eight Partner Booths and Sessions at NVIDIA GTC 202616 Mar 2026 · Newswire · Web pageAible names Mount Sinai as a joint customer for Nebius AI Cloud. Muhammad Parvaz describes moving a locally validated analytical agent to Nebius cloud without moving research data.
Mount Sinai Health System is a nonprofit health care, research, and education organization serving patients across New York City, Westchester, and Long Island. It encompasses seven hospital campuses, more than 400 ambulatory practice locations, the Icahn School of Medicine at Mount Sinai, and the Mount Sinai Phillips School of Nursing. Its services include primary and urgent care, emergency medicine, surgery, cancer treatment, cardiology, pediatrics, and other specialties. It also conducts medical research and provides education for medical, graduate, and nursing students.
Mount Sinai partners with PinkStar to develop breast MRI AI
Mount Sinai will provide clinical data to train and validate PinkStar’s AI technology for breast MRI interpretation. The collaboration will be led through Mount Sinai’s Tisch Cancer Center and Center of Excellence for Breast Cancer.
Mount Sinai receives $3.3 million NIH grant for Ghana hypertension trial
The five-year grant will fund a trial of community-based hypertension care in rural Ghana. Mount Sinai and the Navrongo Health Research Centre will share the funding, with a 504-person trial across 36 communities scheduled to begin in fall 2027.
Mount Sinai receives $1 million gift for pancreatic cancer research
The Blavatnik Family Foundation committed $1 million to support pancreatic cancer research at Mount Sinai. The funding supports work on tumor immune defenses and potential immunotherapy approaches.
Nonprofit health system encompassing hospitals and the Icahn School of Medicine at Mount Sinai. · Health
How they use Nebius AI Cloud
Aible named Mount Sinai as a joint customer in its March 2026 announcement describing planned Nebius AI Cloud demonstrations at NVIDIA GTC. The announcement highlighted agent portability from local devices to Nebius.
Muhammad Parvaz, an associate professor at the Icahn School of Medicine at Mount Sinai, described exploratory analyses of locally stored health-related data using Aible and an NVIDIA DGX Spark / Dell Pro Max GB10 system. All model components ran on the standalone device, keeping data under institutional control. NVIDIA NeMo Guardrails identified potentially sensitive information during processing. After internal validation, the analytical agent was automatically transferred to Nebius cloud without transferring the underlying research data.
Aible announces SafeClaw and Mount Sinai's Nebius research-agent deployment
15 Oct 2026 · ACCESS Newswire · Web page
Aible names Mount Sinai as a joint customer for its Nebius AI Cloud demonstration. Muhammad Parvaz of the Icahn School of Medicine at Mount Sinai describes local exploratory health-data analyses followed by transfer of the validated analytical agent to Nebius without the underlying research data.
Aible announces SafeClaw and Mount Sinai's Nebius research-agent deployment15 Oct 2026 · ACCESS Newswire · Web pageAible names Mount Sinai as a joint customer for its Nebius AI Cloud demonstration. Muhammad Parvaz of the Icahn School of Medicine at Mount Sinai describes local exploratory health-data analyses followed by transfer of the validated analytical agent to Nebius without the underlying research data.
Aible Launches SafeClaw Long-Running Agents and Presents at Eight Partner Booths and Sessions at NVIDIA GTC 2026
16 Mar 2026 · Newswire · Web page
Aible names Mount Sinai as a joint customer for Nebius AI Cloud. Muhammad Parvaz describes moving a locally validated analytical agent to Nebius cloud without moving research data.
Aible Launches SafeClaw Long-Running Agents and Presents at Eight Partner Booths and Sessions at NVIDIA GTC 202616 Mar 2026 · Newswire · Web pageAible names Mount Sinai as a joint customer for Nebius AI Cloud. Muhammad Parvaz describes moving a locally validated analytical agent to Nebius cloud without moving research data.
Mount Sinai Health System is a nonprofit health care, research, and education organization serving patients across New York City, Westchester, and Long Island. It encompasses seven hospital campuses, more than 400 ambulatory practice locations, the Icahn School of Medicine at Mount Sinai, and the Mount Sinai Phillips School of Nursing. Its services include primary and urgent care, emergency medicine, surgery, cancer treatment, cardiology, pediatrics, and other specialties. It also conducts medical research and provides education for medical, graduate, and nursing students.
Mount Sinai partners with PinkStar to develop breast MRI AI
Mount Sinai will provide clinical data to train and validate PinkStar’s AI technology for breast MRI interpretation. The collaboration will be led through Mount Sinai’s Tisch Cancer Center and Center of Excellence for Breast Cancer.
Mount Sinai receives $3.3 million NIH grant for Ghana hypertension trial
The five-year grant will fund a trial of community-based hypertension care in rural Ghana. Mount Sinai and the Navrongo Health Research Centre will share the funding, with a 504-person trial across 36 communities scheduled to begin in fall 2027.
Mount Sinai receives $1 million gift for pancreatic cancer research
The Blavatnik Family Foundation committed $1 million to support pancreatic cancer research at Mount Sinai. The funding supports work on tumor immune defenses and potential immunotherapy approaches.
